biolargo corporate deck 3.5.16
TRANSCRIPT
LOWEST COST
HIGHEST IMPACT
CLEAN WATER TECHNOLOGY
Forward Looking Statements
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual
results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in
BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for
the year ended December 31, 2015.
ABOUT BIOLARGO
2
BioLargo, Inc. platform science &
technology company
leveraging iodine chemistry
to solve some of the world’s
most challenging issues in:
water decontamination
disinfection
wound care
odor elimination
moisture control
Consumer products
Water disinfection / dosing
Water disinfection & decontamination
Wound care & disinfection
EXECUTIVE SUMMARY
Lowest cost, highest impact clean water technology
Capital efficient: $16 million invested since 2007
R&D team & lab located at the University of Alberta
Commercializing patented technology via licensing
Three initial high-value markets being penetrated
Near Term Opportunities > $5 million sales/licensing
Potential for > $50 million licensing fees 2017-18
New Discoveries & Invention Continues at BioLargo
3
OUR MISSION
4
Improve the quality of life for people world-wide,
protect the environment, and produce strong
financial returns for our partners and shareholders.
We plan to do this by using our cutting edge
technologies as a base for developing strategic
corporate partnerships to solve some of the world’s
most serious problems and challenges that threaten
our water, food sources, agriculture and healthcare.
MOST RECENT NEWS
Technology Innovation Leader in the water treatment market by global research company- Frost & Sullivan
“2015 New Product Innovation Award for The Water Treatment Industry – North America”
Copy of report available at www.biolargo.com
5
DISRUPTIVE TECHNOLOGYRECYCLES WATER WITH MAXIMUM EFFICIENCY.
6
TARGETING HIGH-VALUE NEEDS
7
IMPACT MAY EXTEND TO EVERY SEGMENT OF
THE $360 BILLION GLOBAL WATER INDUSTRY
Oil & Gas: Fracking Water Cleanup
United States Market: 500,000 Wells
Revenue per installation: $50,000/well
Oil & Gas: Athabasca Tailing Ponds
United States Market: 700 Tailing Ponds
Revenue per installation: $1,000,000/Pond
Medicine: Advanced Wound Care
United States Market: 6 Million U.S Patients
Revenue per installation: $400/Month/Patient
Maritime Ballast Water Remediation
Worldwide Market: 65,000 Vessels
Revenue per installation: $50,000/vessel
Coal Burning Energy Plants:
Emission Control Waste Water
United States Market: 7,000 Plants
Revenue per installation: $300,000/plant
Coal Mining: Waste-Water Cleanup
United States Market: 3,000 Coal Mines
Revenue per installation: $300,000/mine
Food Processing: Poultry Processing
United States Market: 700 Plants
Revenue per installation $200,000/Plant
8
Total Available Market:
$35 Billion
Coal Burning Energy Plants:
$2 Billion
Food Processing:
$140 Million
Maritime:
$3 Billion
Coal Mining:
$900 Million
Medicine:
$3 Billion
Oil & Gas Industry:
$26 Billion
LICENSING GENERATES LEVERAGED RETURNS
ON ESTABLISHED INTELLECTUAL PROPERTY
9
Typical license of patents and trade secrets includes:
Down Payment
Royalties paid on sales with minimums
Defined time frame (10 – 20 years)
Defined Field of Use / Industry Segment
Mutual protection terms
Opportunity to partner / joint venture is also a
common structure to pool talent, capital, customers
and a work-in-license to accelerate growth
BIOLARGO’S AOS FILTER
Converts a filter into a powerful reactor to manage
and remove harmful contaminants
10
A SCALABLE WATER TECHNOLOGY
THE BIOLARGO ADVANCED
OXIDATION SYSTEM (AOS) FILTER
HOW IT WORKS
11
“Unprecedented Results”
*Professor Lynn McMullen, University of Alberta
Carbon Iodine Chemistry Electricity *Extremely High
Oxidation Potential
UNIQUE VALUE PROPOSITION
When compared to all known competing technologies,
BioLargo’s AOS filter has been proven in hundreds of
lab tests at the University of Alberta to be:
12
up to 100x more effective
1/20th the cost
10x faster
AOS FILTER: HIGHEST IMPACT
Disinfection: +7 log kill (99.99999%)
Removes Soluble Organics
Manages Bacterial BioFilm
Extreme Power Efficiency
Flow-Rate Efficiency (continuous)
Practical application for recapture of waste
stream contaminants
Low Cost (Cap X + Op X)
13
SALMONELLA CASE STUDY
155,000 deaths per year
94 million cases per year
USDA Reports cost at $2.65B annually
The study compared our technology to the industry standard
for combating Salmonella (Chlorine Dioxide)
14
Chlorine Dioxide BioLargo AOS Filter
Total Cells Killed 100,000 10,000,000
Total Contact Time 60 minutes 2 minutes
STUDY RESULTS
PATENTED TECHNOLOGY
Canadian Inventor/Chief Science Officer Ken Code leads the
science team:
– 8 BioLargo researchers
– University of Alberta Staff Support / Collaboration
– 11 Grants totaling >$1Million in 2015
– Additional grants in process (>$1 million level projects)
– 1st Pilot + 6 research projects underway
Extensive patent portfolio
– 15 U.S. patents issued plus PCT Filings
– Additional U.S. patents pending
– IP is expanding
15
ALBERTA SUCCESS STORY
NSERC* Research Chair at
the University of Alberta
(Department of Engineering)
BioLargo is Co-Founding
Member (2011)
Canadian Federal, Provincial
& Industrial Grant Support
for BioLargo Water is
Expanding
16
*Natural Sciences and Engineering Research Council of Canada
PARTNERSHIPS & COLLABORATIONS
17
ASSETS BUILT TO LICENSE:
ADVANCED WOUND CARE
Financing Secured
Proof of Efficacy Accomplished
Pathway to Success is clear for $1B+ opportunity
– 510k pathway – experts contracted & underway Manufacturing, Formulation, Packaging, Labeling, Regulatory
Proven Leadership Team
Liquids, Hydrogels & Dressings
High Profit Margins
18
ASSETS BUILT TO LICENSE:
CONSUMER PRODUCTS ASSETS
Over 30 Fully Developed Products
- Demo Sells Products Instantly
- Multiple Product of the Year Awards
- Best-In-Class (Validated Bureau Veritas)
US Military National Stocking
Numbers in Place (GSA-VA-DLA-DAPA)
New Markets Opening Now (Industrial Odor Control)
Sales Targeted to Increase in 2016
19
ISAN - LICENSED & COMMERCIAL
20
AOS Cylinder
Licensing Agreement with
Clarion Water, royalties to
begin in 2016
LEADERSHIP TEAMDennis Calvert
Chairman, President & CEO 2003 20 years as an entrepreneur, investor and consultant
Kenneth Code
Inventor & CTOFounder
Chemist, Entrepreneur and Creator of BioLargo’s technology
Developing the technology since 1997
Richard Smith, PhD
President, BioLargo Water2014
PhD in Viral Immunopathology &
10+ years working with biotech companies in Alberta, including ChemBioMed and VirRexx
Walter Schindler
Chairman, Advisory Board2015
Leading Cleantech Investor – Venture Capitalist – Business Development Strategist
Attorney & Internationally Recognized Technology Business Builder
Chairman and CEO, Sail Capital LLC.
Vikram Rao, PhD
Senior Advisor 2010
30 years in petroleum industry, former CTO & EVP at Halliburton; ED of Research Triangle
Energy Consortium, author of 40+ publications and holder of 24+ patents
Harry DeLonge
Senior. Advisor 2011
40+ years as Pepsi-Cola’s Int’l V.P. of Technical Services & V.P. of Manufacturing Technology
Water Expert
Joseph Provenzano
V.P. of Operations2003 15 years in mergers and acquisitions, operations and marketing
Robert Szolomayer
Dir. of Corp. Development2004 35 years in Real Estate; five years managing $1B Northrop Grumman project
Steve Harrison
Dir. of Int’l Ventures 2003 25 years of experience as an Entrepreneur and Business Founder beyond U.S. soil
Tanya Rhodes PhD
CTO Clyra Medical2013
Chemistry PhD
25 years advanced wound care industry, Sr. VP, Regulatory & Innovation Smith and Nephew
AJ Sexton V
Dir. of Bus. Development2014 25 years Investment Banking, License FINRA Series 7, 63 and 79 licenses
21
KEY BENCHMARKS AHEAD
AOS market-ready prototype contracted for delivery August 2016
Successful Commercial Scale Pilots
Expanded Grants / Collaborations
Establish strategic partnerships
New capital is required for product development,
manufacturing and launch products
Expand Existing Orders
First AOS Commercial Sales
Fortify the Management Team
Extend Marketing and Sales
Target Up-List to NASDAQ
22
Company Contact:
Dennis Calvert
President & CEO
BioLargo, Inc.
(949) [email protected]
www.biolargo.com